Related references
Note: Only part of the references are listed.Structural Insight into PPARγ Activation Through Covalent Modification with Endogenous Fatty Acids
Tsuyoshi Waku et al.
JOURNAL OF MOLECULAR BIOLOGY (2009)
Subchronic infusion of the product of inflammation prostaglandin J2 models sporadic Parkinson's disease in mice
Sha-Ron Pierre et al.
JOURNAL OF NEUROINFLAMMATION (2009)
A designed chimeric cyanovirin-N homolog lectin: Structure and molecular basis of sucrose binding
Leonardus M. I. Koharudin et al.
PROTEINS-STRUCTURE FUNCTION AND BIOINFORMATICS (2009)
15-deoxy-Delta(12,14)-prostaglandin J(2): An electrophilic trigger of cellular responses
Koji Uchida et al.
CHEMICAL RESEARCH IN TOXICOLOGY (2008)
Aberrant molecular properties shared by familial Parkinson's disease-associated mutant UCH-L1 and carbonyl-modified UCH-L1
Tomohiro Kabuta et al.
HUMAN MOLECULAR GENETICS (2008)
Aberrant interaction between Parkinson disease-associated mutant UCH-L1 and the lysosomal receptor for chaperone-mediated autophagy
Tomohiro Kabuta et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2008)
15-deoxy-Δ12,14-prostaglandin J2 inhibits transcriptional activity of estrogen receptor-α via covalent modification of DNA-binding domain
Han-Jong Kim et al.
CANCER RESEARCH (2007)
Identification of actin as a 15-deoxy-Δ12,14-prostaglandin J2 target in neuroblastoma cells:: Mass spectrometric, computational, and functional approaches to investigate the effect on cytoskeletal derangement
Giancarlo Aldini et al.
BIOCHEMISTRY (2007)
Protein oxidation and lipid peroxidation in brain of subjects with Alzheimer's disease: Insights into mechanism of neuro degeneration from redox proteomics
Rukhsana Sultana et al.
ANTIOXIDANTS & REDOX SIGNALING (2006)
Structural basis for conformational plasticity of the Parkinson's disease-associated ubiquitin hydrolase UCH-L1
C Das et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
The cyclopentenone (A(2)/J(2)) isoprostanes - Unique, highly reactive products of arachidonate peroxidation
GL Milne et al.
ANTIOXIDANTS & REDOX SIGNALING (2005)
Protein posttranslational modifications: The chemistry of proteome diversifications
CT Walsh et al.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2005)
Oxidative modifications and down-regulation of ubiquitin carboxyl-terminal hydrolase L1 associated with idiopathic Parkinson's and Alzheimer's diseases
J Choi et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
Induction of reversible cysteine-targeted protein oxidation by an endogenous electrophile 15-deoxy-Δ12,14-prostaglandin J2
T Ishii et al.
CHEMICAL RESEARCH IN TOXICOLOGY (2004)
Δ12-prostaglandin J2 inhibits the ubiquitin hydrolase UCH-L1 and elicits ubiquitin-protein aggregation without proteasome inhibition
ZM Li et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2004)
UCSF chimera - A visualization system for exploratory research and analysis
EF Pettersen et al.
JOURNAL OF COMPUTATIONAL CHEMISTRY (2004)
Molecular basis for the direct inhibition of AP-1 DNA binding by 15-deoxy-Δ12,14-prostaglandin J2
D Pérez-Sala et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Ubiquitin carboxy-terminal hydrolase L1 binds to and stabilizes monoubiquitin in neuron
H Osaka et al.
HUMAN MOLECULAR GENETICS (2003)
Thioredoxin as a molecular target of cyclopentenone prostaglandins
T Shibata et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Cyclooxygenase-2 is instrumental in Parkinson's disease neurodegeneration
P Teismann et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
Alterations of structure and hydrolase activity of Parkinsonism-associated human ubiquitin carboxyl-terminal hydrolase L1 variants
K Nishikawa et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2003)
The cyclopentenone 15-deoxy-Δ12,14-prostagland in J2 binds to and activates H-Ras
JL Oliva et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
The UCH-L1 gene encodes two opposing enzymatic activities that affect α-synuclein degradation and Parkinson's disease susceptibility
YC Liu et al.
CELL (2002)
15-deoxy-Δ12,14-prostaglandin J2 -: A prostaglandin D2 metabolite generated during inflammatory processes
T Shibata et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Cyclopentenone prostaglandins as potential inducers of intracellular oxidative stress
M Kondo et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
15-deoxy-Δ12,14-prostaglandin J2 inhibits multiple steps in the NF-κB signaling pathway
DS Straus et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2000)
Share Paper
